NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, a pioneering leader in the development of innovative, scalable and trusted weight loss experiences, today announced new clinical data on the ...

NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, an established leader in the development of innovative, proven, and trusted weight loss experiences, today announced the Premarket Approval (PMA) ...

New research shows Allurion Technologies’ Elipse balloon is a safe and effective procedureless weight-loss treatment, according to Science Daily. Researchers presented the data at the European Obesity ...

Allurion Technologies is hoping to be able to get FDA approval to launch its obesity treatment balloon in 2020. The Natick, MA-based company said it was making progress toward its goal of getting ...

Allurion Technologies is one step closer to having its Elipse gastric balloon enter the U.S. market. The Natick, MA-based company announced the PMA submission of the device early Tuesday. The ...

Allurion, a Boston-based startup offering a non-invasive gastric balloon by swallowing a pill, has gained $27 million in Series C funding from previous investor Romulus Capital, with new participation ...

A Natick weight loss device company has begun a clinical trial in the U.S. with the hopes of soon gaining U.S. Food and Drug Administration approval. Allurion Technologies, makers of a gastric balloon ...

Allurion Technologies has launched its ENLIGHTEN clinical study of Elipse, a weight loss balloon swallowed via capsule and filled with liquid through a catheter, thereby avoiding surgery for patients ...

Allurion Technologies announced today two major milestones with the launch of the transformed Allurion Weight Loss Program and new worldwide brand for the company and its program. This press release ...

Just swallow a pill and it expands into a balloon in your stomach so you don’t feel hungry. No gastric bypass, no surgery required. Sounds magical, but Boston-based Allurion has created the only ...

The market for intragastric balloons to enable weight loss is just getting started in the U.S. after a pair of FDA approvals last summer for the first devices in this category--although it's been in ...

Allurion CEO Shantanu Gaur, right, speaks at the company's ribbon-cutting event Friday for its new Natick office and laboratory. Ram Chuttani, the company's chief medical officer, left, and Samuel ...